Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
FlashNews:
WhatsLove AI: What Is an Immersive AI Girlfriend With Video Chat
Foot Locker and Nike Introduce New Store Created With Community Leaders
US Treasury moves forward with rules on GENIUS Act after July deadline
Chelsea shareholders Walter and Boehly in talks to sell stakes to Clearlake
Bitcoin hits $64K as gold gains while oil shakes off Trump Oman threat
Did you solve it? A new goat for puzzledom’s GOAT
Digital Heroes Expands Its Software and Mobile App Development Services in 2026
‘Look in the mirror. That’s the trick’: our fashion expert Jess Cartner-Morley answered your questions
Tributes paid to Heroes actress Hayden Panettiere who has died aged 36
Venue admits scrapping Jewish comedian’s Edinburgh Fringe show was discrimination
Kushner holds talks with Netanyahu after meeting Hamas leader
Europe Captures One-Third of Global Leisure Travel Spending as Southern Europe Dominates the Summer
The Egyptian Tourism Authority Joins the World Travel & Tourism Council as a Destination Partner
Russian E-Tailer Wildberries Hit by Wave of Ukrainian Drone Strikes
7 Best Cheap Laptops to Buy in 2026 (and Some to Avoid)
CookUnity Prepared Meal Delivery Review (2026): Chef-Centric Meals
Why Founders Brick Was Built: Rethinking Modern Wealth Management
What Makes a Modern Investment Company Different From Traditional Financial Institutions?
Veritron Compliance Group Launches To Address Growing Digital Compliance Crisis
Home » Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute